Mar 25 (Reuters)-
Cosmo Bio Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2019 Dec 31, 2018 Dec 31, 2020 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 7.59 7.26 7.75 3.90
(+4.5 pct) (+2.7 pct) (+2.1 pct) (+2.8 pct)
Operating 405 mln 328 mln 430 mln 250 mln
(+23.5 pct) (+70.1 pct) (+6.0 pct) (+3.7 pct)
Recurring 470 mln 403 mln 490 mln 290 mln
(+16.5 pct) (+1.6 pct) (+4.1 pct) (+7.5 pct)
Net
Net 237 mln 260 mln 310 mln 180 mln
(-8.6 pct) (+9.4 pct) (+30.3 pct) (+0.3 pct)
EPS 40.14 yen 43.93 yen 52.29 yen 30.36 yen
Ann Div 14.00 yen 14.00 yen 18.00 yen
-Q2 Div 6.00 yen 6.00 yen 8.00 yen
-Q4 Div 8.00 yen 8.00 yen 10.00 yen
NOTE - Cosmo Bio Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T